These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 36250732)

  • 1. Skin Eosinophil Counts in Bullous Pemphigoid as a Prognostic Factor for Disease Severity and Treatment Response.
    Baum S; Engler Markowitz M; Lyakhovitsky A; Gershon R; Aviv H; Segal Z; Barzilai A
    Acta Derm Venereol; 2023 Jan; 103():adv00850. PubMed ID: 36250732
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tissue eosinophil levels as a marker of disease severity in bullous pemphigoid.
    Gore Karaali M; Koku Aksu AE; Cin M; Leblebici C; Kara Polat A; Gurel MS
    Australas J Dermatol; 2021 May; 62(2):e236-e241. PubMed ID: 33748980
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of Peripheral Blood and Cutaneous Eosinophils With Bullous Pemphigoid Disease Severity and Treatment Outcomes.
    Garrido PM; Aguado-Lobo M; Espinosa-Lara P; Soares-Almeida L; Filipe P
    Actas Dermosifiliogr; 2022 Oct; 113(9):881-887. PubMed ID: 35659610
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deposition of eosinophil granule proteins precedes blister formation in bullous pemphigoid. Comparison with neutrophil and mast cell granule proteins.
    Borrego L; Maynard B; Peterson EA; George T; Iglesias L; Peters MS; Newman W; Gleich GJ; Leiferman KM
    Am J Pathol; 1996 Mar; 148(3):897-909. PubMed ID: 8774144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence for a role of eosinophils in blister formation in bullous pemphigoid.
    de Graauw E; Sitaru C; Horn M; Borradori L; Yousefi S; Simon HU; Simon D
    Allergy; 2017 Jul; 72(7):1105-1113. PubMed ID: 28135772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunomodulator Galectin-9 is Increased in Blood and Skin of Patients with Bullous Pemphigoid.
    Pruessmann J; Pruessmann W; Holtsche MM; Linnemann B; Hammers CM; van Beek N; Zillikens D; Schmidt E; Sadik CD
    Acta Derm Venereol; 2021 Mar; 101(3):adv00419. PubMed ID: 33606034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Eosinophil Cationic Protein (ECP), a predictive marker of bullous pemphigoid severity and outcome.
    Giusti D; Gatouillat G; Le Jan S; Plée J; Bernard P; Antonicelli F; Pham BN
    Sci Rep; 2017 Jul; 7(1):4833. PubMed ID: 28684769
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum eosinophil cationic protein (ECP) in bullous pemphigoid.
    Caproni M; Palleschi GM; Falcos D; D'Agata A; Cappelli G; Fabbri P
    Int J Dermatol; 1995 Mar; 34(3):177-80. PubMed ID: 7751092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Role of Eosinophils in Bullous Pemphigoid: A Developing Model of Eosinophil Pathogenicity in Mucocutaneous Disease.
    Amber KT; Valdebran M; Kridin K; Grando SA
    Front Med (Lausanne); 2018; 5():201. PubMed ID: 30042946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characteristics of patients with bullous pemphigoid: comparison of classic bullous pemphigoid to non-bullous pemphigoid.
    Ben Mordehai Y; Faibish H; Astman N; Greenberger S; Barzilai A; Baum S
    J Eur Acad Dermatol Venereol; 2020 Jan; 34(1):161-165. PubMed ID: 31423677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cellular events leading to blister formation in bullous pemphigoid.
    Dubertret L; Bertaux B; Fosse M; Touraine R
    Br J Dermatol; 1980 Dec; 103(6):615-24. PubMed ID: 7006666
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Evaluation of histological criteria for bullous pemphigoid. Correlation with antigens recognized by immunoblotting of anti-epidermal autoantibodies].
    Courville P; Kupfer I; Gilbert D; Thomine E; Metayer J; Joly P
    Ann Pathol; 2000 Dec; 20(6):564-9. PubMed ID: 11148352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-dose oral methotrexate induces apoptosis of tissue eosinophils in bullous pemphigoid.
    Dahlman-Ghozlan K; Ortonne JP; Bahadoran P; Spadafora A; Stephansson E
    Acta Derm Venereol; 2008; 88(3):219-22. PubMed ID: 18480918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Eosinophil localization to the basement membrane zone is autoantibody- and complement-dependent in a human cryosection model of bullous pemphigoid.
    Messingham KN; Wang JW; Holahan HM; Srikantha R; Aust SC; Fairley JA
    Exp Dermatol; 2016 Jan; 25(1):50-5. PubMed ID: 26475989
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Eosinophil cationic protein levels parallel coagulation activation in the blister fluid of patients with bullous pemphigoid.
    Tedeschi A; Marzano AV; Lorini M; Balice Y; Cugno M
    J Eur Acad Dermatol Venereol; 2015 Apr; 29(4):813-7. PubMed ID: 24650303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Eosinophil-colony stimulating activity in blister fluid of bullous pemphigoid.
    Kawachi Y; Otsuka F
    J Dermatol Sci; 1997 May; 15(1):51-4. PubMed ID: 9186812
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decrease in eosinophils infiltrating into the skin of patients with dipeptidyl peptidase-4 inhibitor-related bullous pemphigoid.
    Chijiwa C; Takeoka S; Kamata M; Tateishi M; Fukaya S; Hayashi K; Fukuyasu A; Tanaka T; Ishikawa T; Ohnishi T; Watanabe S; Tada Y
    J Dermatol; 2018 May; 45(5):596-599. PubMed ID: 29411416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of coagulation in bullous pemphigoid and other eosinophil-related inflammatory skin diseases.
    Marzano AV; Tedeschi A; Berti E; Fanoni D; Crosti C; Cugno M
    Clin Exp Immunol; 2011 Jul; 165(1):44-50. PubMed ID: 21488867
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alteration in the density, morphology, and biological properties of eosinophils produced by bullous pemphigoid blister fluid.
    Miyasato M; Tsuda S; Kasada M; Iryo K; Sasai Y
    Arch Dermatol Res; 1989; 281(5):304-9. PubMed ID: 2552935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dual role of basophils in the pathogenesis of bullous pemphigoid elucidated by pathological and ultrastructural studies.
    Kimura R; Sugita K; Horie T; Yamamoto O
    Eur J Dermatol; 2022 May; 32(3):322-333. PubMed ID: 36065540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.